RaymondFrancisAntonJr.MD

Psychiatry • Charleston, SC

Addiction

Professor, Psychiatry and Behavioral Sciences, Medical University of South Carolina College of Medicine

Join to view full profile

Dr. Anton is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Anton's full profile

Already have an account?

Office
67 President St 4north
Charleston, SC 29425
Phone+1 843-722-6309

Education & Training

Yale-New Haven Medical CenterResidency, Psychiatry, 1977 - 1980
Greenwich HospitalInternship, Transitional Year, 1976 - 1977
Rutgers Robert Wood Johnson Medical SchoolClass of 1976

Certifications & Licensure

SC State Medical License 1980 - 2023
American Board of Psychiatry and Neurology Psychiatry

Clinical Trials

Effectiveness of Gabapentin When Used With Naltrexone to Treat Alcohol Dependence Compared to Placebo and Naltrexone Alone Start of enrollment: 2003 Jan 01
Completed
Phase 3
Effectiveness of Naltrexone and/or Ondansetron to Reduce Craving for Alcohol and Drinking Start of enrollment: 2005 May 01
Completed
Phase 2
Aripiprazole Effects on Alcohol Reactivity and Consumption Start of enrollment: 2005 Jun 01
Completed
Phase 2
Prometa Protocol for Alcohol Dependence Start of enrollment: 2005 Dec 01
Completed
Phase 2, Phase 3
Effectiveness of Naltrexone Versus Placebo to Reduce Craving for Alcohol With Evaluation of Genetic Variability. Start of enrollment: 2006 Apr 01
Completed
Phase 4
An Exploratory Study of Naltrexone Plus Aripiprazole for Alcohol Dependence Start of enrollment: 2008 Apr 01
Completed
Phase 2
Genetic and Brain Mechanisms of Naltrexone's Treatment Efficacy for Alcoholism Start of enrollment: 2009 Jun 01
Completed
Phase 4
Aripiprazole Effects on Alcohol Drinking and Craving Start of enrollment: 2011 Feb 01
Completed
Phase 3
Effect of GET73 on MRS Measures of Central Glutamate and GABA in Individuals With Alcohol Use Disorder Start of enrollment: 2018 Mar 08
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

20 citations
Systematic review and meta-analysis of the moderating effect of rs1799971 in OPRM1, the mu-opioid receptor gene, on response to naltrexone treatment of alcohol use dis...
Emily E. Hartwell, Richard Feinn, Paige E. Morris, Joel Gelernter, John H. Krystal
Addiction. 2020-02-11
307 citations
An evaluation of μ-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: Results from the combined pharmacotherapies an...
Raymond F. Anton, Gabor Oroszi, Stephanie S. O'Malley, David Couper, Robert M. Swift
Archives of General Psychiatry. 2008-02-01
43 citations
A double-blind, placebo-controlled trial of sertraline in depressed adolescent alcoholics: a pilot study.
Deborah Deas, Carrie L. Randall, James S. Roberts, Raymond F. Anton
Human Psychopharmacology. 2000-08-01

Press Mentions

New Study Examines Link Between Alcohol Consumption and CancerSeptember 17th, 2021
Drug Eases Withdrawal, Improves Abstinence in Alcohol Use DisorderMarch 9th, 2020
The Mu Opioid Receptor Genotype May Be a Marker for Those Who Drink for Alcohol's Rewarding EffectsDecember 14th, 2012
Join now to see all

Grant Support

Rc4 Impulsivity And Drinking/Craving: Effect Of A Dopamine Stabilizer MedicationNational Institute On Alcohol Abuse And Alcoholism2011–2012
Genetic And Brain Mechanisms Of Naltrexone'S Treatment Efficacy For AlcoholismNational Institute On Alcohol Abuse And Alcoholism2009–2012
Career Development And Mentoring In Clinical/Translational Alcohol ResearchNational Institute On Alcohol Abuse And Alcoholism2008–2011
Evaluating The Genetic Variability Of Naltrexone ResponseNational Institute On Alcohol Abuse And Alcoholism2006–2010
An Exploratory Study Of Naltrexone PLUS Aripiprazole For Alcohol DependenceNational Institute On Alcohol Abuse And Alcoholism2008–2009
Pilot CoreNational Institute On Alcohol Abuse And Alcoholism2006–2007
Gabapentin As An Adjunct To Naltrexone For AlcoholismNational Institute On Alcohol Abuse And Alcoholism2002–2006
Naltrexonel/Acamprosate And CBT/MET Light For AlcoholismNational Institute On Alcohol Abuse And Alcoholism2003–2004
Effect Of Naltrexone And Ondansetron On AlcoholismNational Institute On Alcohol Abuse And Alcoholism2001–2002
Training In Alcohol Treatment ResearchNational Institute On Alcohol Abuse And Alcoholism1998–2002
Naltrexone/Acamprosate PLUS CBT/MET Light For AlcoholismNational Institute On Alcohol Abuse And Alcoholism1997–2002
Comparison Of CBT And MET PLUS Naltrexone For AlcoholismNational Institute On Alcohol Abuse And Alcoholism1997–2001
Opiate Antagonist--Alcohol Reactivity And ConsumptionNational Institute On Alcohol Abuse And Alcoholism1996–2000
Naltrexone And Cognitive Behavior Therapy Of AlcoholismNational Institute On Alcohol Abuse And Alcoholism1992–1996

Professional Memberships

American Society of Addiction Medicine - ASAM
Member